Related Experiment Video
Updated: May 6, 2026
06:38
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
Published on: February 28, 2025
768
Two new glycosides from Carduus acanthoides
Sui-Ku Liu1, Sheng Que, Wei Cheng
1a State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center , Beijing , 100191 , China.
Journal of Asian Natural Products Research
|November 5, 2013
Summary
Two novel glycosides were identified in Carduus acanthoides plants. These compounds, syringic acid-4-O-β-L-arabinopyranoside and kaempferol-3-O-α-L-rhamnopyranosyl-7-O-β-D-glucuronopyranoside, were characterized using spectroscopic methods.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
Background:
- Carduus acanthoides (Asteraceae) is a plant species with potential for novel compound discovery.
- Glycosides are a significant class of natural products with diverse biological activities.
Purpose of the Study:
- To isolate and characterize new glycosides from Carduus acanthoides.
- To elucidate the chemical structures of the isolated compounds.
Main Methods:
- Extraction of secondary metabolites from whole plants of Carduus acanthoides.
- Purification of glycosides using chromatographic techniques.
- Structure elucidation employing various spectroscopic analyses (e.g., NMR, MS).
Main Results:
- Isolation of two previously undescribed glycosides: syringic acid-4-O-β-L-arabinopyranoside and kaempferol-3-O-α-L-rhamnopyranosyl-7-O-β-D-glucuronopyranoside.
- Comprehensive structural characterization of both compounds based on detailed spectroscopic data.
Conclusions:
- The study successfully identified and characterized two new glycosides from Carduus acanthoides.
- These findings contribute to the phytochemical knowledge of the Asteraceae family and natural product diversity.
Related Concept Videos
01:26Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
958
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
958
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
01:30Adrenergic Agonists: Direct-Acting Agents
2.8K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
2.8K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.4K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.4K